Personal information

United States

Activities

Employment (2)

UTsouthwestern medical center: Dallas, Texas, US

2023-07-01 to present | Postdoctoral research scholar (Infectious diseases)
Employment
Source: Self-asserted source
Leila Fotooh Abadi

David Geffen School of Medicine, University of California, Los Angeles: CA, CA, US

2023-01-02 to 2023-03-31 | Postdoctoral research scholar (Infectious diseases)
Employment
Source: Self-asserted source
Leila Fotooh Abadi

Education and qualifications (1)

National AIDS Research Institute: Pune, Maharashtra, IN

2014-08-21 to 2022-08-02 | PhD (Virology )
Education
Source: Self-asserted source
Leila Fotooh Abadi

Professional activities (5)

The British Society for Nanomedicine: Liverpool, Merseyside, GB

2022-02-11 to present | Student (Virology )
Membership
Source: Self-asserted source
Leila Fotooh Abadi

World society for virology: Saudi Arabia, SA

2019-04-19 to present | Early Stage
Membership
Source: Self-asserted source
Leila Fotooh Abadi

International AIDS Society: Geneva, CH

2018-07-21 to present | Researcher Member
Membership
Source: Self-asserted source
Leila Fotooh Abadi

American Society for Microbiology: Washington, DC, US

2009-03-09 to present
Membership
Source: Self-asserted source
Leila Fotooh Abadi

Universität Bern, Theodor Kocher Institute : Bern, Bern, CH

2020-10-18 to 2021-01-14 | Research Intern (Medical Faculty)
Invited position
Source: Self-asserted source
Leila Fotooh Abadi

Funding (3)

Assessment of transmigration of nanoparticles across human blood–brain barrier model.

2020-10 to 2021-01 | Grant
European Molecular Biology Organization (Heidelberg, DE)
Source: Self-asserted source
Leila Fotooh Abadi

AIDS2018

2018-07 to present | Award
International AIDS Society (Geneva, CH)
Source: Self-asserted source
Leila Fotooh Abadi

Fellowship award

2017-02 to present | Award
National AIDS Control Organization, Division of the Ministry of Health and Family Welfare, Government of India (New Delhi , New Delhi , IN)
Source: Self-asserted source
Leila Fotooh Abadi

Works (15)

Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level

The Journal of Infectious Diseases
2024-01-12 | Journal article
Part of ISSN: 0022-1899
Part of ISSN: 1537-6613
Contributors: Leila Fotooh Abadi; Madhav B Sharma; Theodoros Kelesidis
Source: Self-asserted source
Leila Fotooh Abadi

The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections

Pathogens
2023-12-31 | Journal article
Part of ISSN: 2076-0817
Contributors: Maria Daskou; Leila Fotooh Abadi; Chandrima Gain; Michael Wong; Eashan Sharma; Arnaud John Kombe Kombe; Ravikanth Nanduri; Theodoros Kelesidis
Source: Self-asserted source
Leila Fotooh Abadi

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo

The Journal of Infectious Diseases
2023-12-18 | Journal article
Part of ISSN: 0022-1899
Part of ISSN: 1537-6613
Contributors: Michael Wong; Chandrima Gain; Madhav B Sharma; Leila Fotooh Abadi; Cristelle Hugo; Hariclea Vassilopoulos; Maria Daskou; Gregory A Fishbein; Theodoros Kelesidis
Source: Self-asserted source
Leila Fotooh Abadi

Tenofovir alafenamide fumarate loaded long-acting microsphere for HIV pre-exposure prophylaxis

Journal of Drug Delivery Science and Technology
2023-09 | Journal article
Contributors: Manoj A. Pawar; Leila Fotooh Abadi; Satish V. Rojekar; Ankita N. Yawalkar; Smita S. Kulkarni; Pradeep R. Vavia
Source: check_circle
Crossref

HIV-1 exploits Hes-1 expression during pre-existing HPV-16 infection for cancer progression

VirusDisease
2023-03 | Journal article
Contributors: Serena D’Souza; Arati Mane; Linata Patil; Aazam Shaikh; Madhuri Thakar; Vandana Saxena; Leila Fotooh Abadi; Sheela Godbole; Smita Kulkarni; Raman Gangakhedkar et al.
Source: check_circle
Crossref

Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept

Journal of Nanobiotechnology
2023-01-19 | Journal article
Part of ISSN: 1477-3155
Contributors: Leila Fotooh Abadi; Pramod Kumar; Kishore Paknikar; Virendra Gajbhiye; Smita Kulkarni
Source: Self-asserted source
Leila Fotooh Abadi

Mannose-Anchored Nano-Selenium Loaded Nanostructured Lipid Carriers of Etravirine for Delivery to HIV Reservoirs

AAPS PharmSciTech
2022-08-17 | Journal article | Conceptualization, Data curation, Methodology
Part of ISSN: 1530-9932
Contributors: Leila Fotooh Abadi
Source: Self-asserted source
Leila Fotooh Abadi

Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs

Polymers
2022-07 | Journal article | Author
Contributors: Leila Fotooh Abadi; FOUAD DAMIRI; Mehrukh Zehravi; Rohit Joshi; Rohan Pai; Mohammed Berrada; Ehab El Sayed Massoud; Md. Habibur Rahman; Satish Rojekar; DANIELA SIMONA CAVALU
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept

European Journal of Pharmaceutical Sciences
2021 | Journal article
EID:

2-s2.0-85110074266

Part of ISSN: 18790720 09280987
Contributors: Rojekar, S.; Fotooh Abadi, L.; Pai, R.; Mahajan, K.; Kulkarni, S.; Vavia, P.R.
Source: Self-asserted source
Leila Fotooh Abadi via Scopus - Elsevier

Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy

International Journal of Pharmaceutics
2021-09 | Journal article
Part of ISSN: 0378-5173
Source: Self-asserted source
Leila Fotooh Abadi

Non-nuke HIV-1 inhibitor shuttled by mesoporous silica nanoparticles effectively slows down HIV-1 replication in infected human cells

Colloids and Surfaces B: Biointerfaces
2020-10 | Journal article
Source: Self-asserted source
Leila Fotooh Abadi
grade
Preferred source (of 2)‎

Abstracts from the International Science Symposium on HIV and Infectious Diseases (ISSHID 2019): Infectious diseases

BMC Infectious Diseases
2020-05 | Journal article
Part of ISSN: 1471-2334
Source: Self-asserted source
Leila Fotooh Abadi

Design, Synthesis and In Vitro Evaluation of Novel Anti-HIV 3-Pyrazol-3- yl-Pyridin-2-One Analogs

Medicinal Chemistry
2019 | Journal article
EID:

2-s2.0-85068527028

Contributors: Kumar, S.; Gupta, S.; Gaikwad, S.; Abadi, L.F.; Bhutani, L.K.K.; Kulkarni, S.; Singh, I.P.
Source: Self-asserted source
Leila Fotooh Abadi via Scopus - Elsevier

Synthesis and in–vitro anti–HIV–1 evaluation of novel pyrazolo[4,3–c]pyridin–4–one derivatives

European Journal of Medicinal Chemistry
2019 | Journal article
EID:

2-s2.0-85072394098

Contributors: Kumar, S.; Gupta, S.; Abadi, L.F.; Gaikwad, S.; Desai, D.; Bhutani, K.K.; Kulkarni, S.; Singh, I.P.
Source: Self-asserted source
Leila Fotooh Abadi via Scopus - Elsevier

Synthesis and Biological Evaluation of 8-Hydroxyquinoline-hydrazones for Anti-HIV-1 and Anticancer Potential

ChemistrySelect
2018 | Journal article
EID:

2-s2.0-85055017820

Contributors: Shah, P.; Abadi, L.F.; Gaikwad, S.; Chaudhari, D.; Kushwah, V.; Jain, S.; Bhutani, K.K.; Kulkarni, S.; Singh, I.P.
Source: Self-asserted source
Leila Fotooh Abadi via Scopus - Elsevier